{
  "url": "https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.2/division-1",
  "json_url": "https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.2/division-1.json",
  "legislation": "eudn/2018/945",
  "legislation_title": "Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-decision-2018-945",
  "path": "annex/II/division/3/division/3.2/division/1",
  "kind": "division",
  "number": null,
  "heading": "Clinical Criteria",
  "text": "Any person with at least one of the following clinical forms:\nFood-borne and wound botulism\nAt least one of the following two:\nBilateral cranial nerve impairment (for example, diplopia, blurred vision, dysphagia, bulbar weakness);\nPeripheral symmetric paralysis.\nInfant botulism\nAny infant with at least one of the following six:\nConstipation;\nLethargy;\nDifficulty in sucking or feeding;\nPtosis;\nDysphagia;\nGeneral muscle weakness.\nThe type of botulism usually encountered in infants (< 12 months of age) can affect children also over 12 months of age and occasionally adults, with altered gastrointestinal anatomy and microflora",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.2/division/1",
    "retrieved_at": "2026-11-01T15:13:03.598650+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}